Description
FARROWSURE® PLUS is a liquid preparation of porcine parvovirus grown on an established porcine cell line, a serum-free, clarified E. rhusiopathiae culture, and whole cell cultures of the 5 Leptospira serovars identified below. The antigens have been chemically inactivated and adjuvanted with 2 adjuvants, including Amphigen®, to enhance the immune response.
Approved Uses
Vaccination of healthy breeding swine as an aid in preventing reproductive failure caused by porcine parvovirus (PPV), erysipelas caused by Erysipelothrix rhusiopathiae, and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona. A 26-week duration of immunity following vaccination has been demonstrated against erysipelas.
Key Features
FARROWSURE PLUS is the only vaccine with a labeled duration of immunity against erysipelas of 26 weeks.
The duration of immunity of 26 weeks provides for litter-to-litter erysipelas protection.
The only reproductive vaccine that contains Amphigen.
FARROWSURE PLUS optimizes breeding-herd performance by controlling erysipelas, parvovirus and leptospirosis with minimum vaccination stress.
By controlling these diseases, farrowing rates and number of pigs born alive can be improved, and non-productive sow days can be reduced.
Packaging
50-dose and 100-dose vials